Literature DB >> 21546297

Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue type arising in the pleura with pleural fibrous plaques in a lathe worker.

Shin-ichi Nakatsuka1, Teruaki Nagano, Hayato Kimura, Shoji Hanada, Hidetoshi Inoue, Takashi Iwata.   

Abstract

Our patient was an 86-year-old man who had worked as a lathe operator for 40 years. He had no history of tuberculosis, pyothorax, or autoimmune disease. He had not been exposed to asbestos. He was asymptomatic, but an imaging study showed gradually increasing pleural plaques. A biopsy specimen of a pleural lesion showed sclerosis of the pleura and diffuse infiltration of small- to medium-sized B lymphocytes. Polymerase chain reaction-based analysis detected monoclonal rearrangement of immunoglobulin heavy-chain genes. Histologic diagnosis was extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue type (MALT lymphoma). The lymphoma was negative for Epstein-Barr virus. We report a rare case of a metal worker with MALT lymphoma arising in the pleura with pleural fibrous plaques. It is speculated that MALT lymphoma might develop in the background of pneumoconiosis. Inflammatory and/or immunologic reactions to metal particles might contribute to the oncogenesis of this tumor.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21546297     DOI: 10.1016/j.anndiagpath.2011.02.003

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  2 in total

1.  Primary Pleural Extranodal Marginal Zone Lymphoma Presenting as Bilateral Chylothorax.

Authors:  Thushara Paul; Dhiraj Kumar Yadav; Mohamed Alhamar; Vrushali Dabak
Journal:  Case Rep Oncol       Date:  2020-07-30

2.  Misdiagnosis of primary mucosa-associated lymphoid tissue lymphoma of the pleura: case report and literature review.

Authors:  Yao-Hui Wang; Ling Peng; Jie-Han Jiang; Yun Xiao; Zhi-Ruo Zhu; Zhi-Hui Shi; Wen-Long He; Qing-Wu Qin; Ding Liang; Yi Jiang; Hong Luo; Rui Zhou; Kui Xiao
Journal:  Transl Cancer Res       Date:  2022-09       Impact factor: 0.496

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.